Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)
Taiwan · Delayed Price · Currency is TWD 41.30
+0.10 (0.24%)
Aug 4, 2026, 12:54 PM CST
Anti-Microbial Savior BioteQ Company Description
Anti-Microbial Savior BioteQ Co., Ltd. focuses on the research and development of pharmaceutical drug products in Taiwan.
The company offers PoroVance precision pore engineering and small-molecule drug discovery. Its pipeline products include FORMOSA-1117, antibacterial drug candidate; YUAN-03, antiviral drug candidate; AMS-2140, broad-spectrum antiviral drug candidate; TenTacle, ADC linker-conjugate compound.
Anti-Microbial Savior BioteQ Co., Ltd. was founded in 2018 and is headquartered in Kaohsiung, Taiwan.
Anti-Microbial Savior BioteQ Co., Ltd.
| Country | Taiwan |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Zhida Wei |
Contact Details
Address: No. 6, Siwei 3rd Rd. Kaohsiung, 802 Taiwan | |
| Phone | 886 7 223 7578 |
| Website | ams-bioteq.com |
Stock Details
| Ticker Symbol | 6864 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006864002 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Zhida Wei | Chief Executive Officer and Director |
| Dr. George Tsai | GM and Chairman |
| Yi-Wei Zhang | President |
| Li Yu Xu | Head of Finance and Accounting Supervisor |
| Nicolas Liu | Head of Finance Management Department |
| Felix Tsai | Chief Business Officer |